Nicholas Stephen Bodor
#132,142
Most Influential Person Now
Nicholas Stephen Bodor's AcademicInfluence.com Rankings
Nicholas Stephen Bodorphilosophy Degrees
Philosophy
#6468
World Rank
#9508
Historical Rank
Logic
#3628
World Rank
#4819
Historical Rank
Download Badge
Philosophy
Why Is Nicholas Stephen Bodor Influential?
(Suggest an Edit or Addition)Nicholas Stephen Bodor's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. (1997) (517)
- Soft drug design: General principles and recent applications (2000) (189)
- Site-specific, sustained release of drugs to the brain. (1981) (166)
- Problems of delivery of drugs to the brain. (1982) (158)
- Neural network studies: Part 3. Prediction of partition coefficients (1994) (155)
- Octanol-water partition: searching for predictive models. (1998) (135)
- Use of 2-Hydroxypropyl-β-cyclodextrin as a Solubilizing and Stabilizing Excipient for Protein Drugs (1991) (121)
- A strategy for delivering peptides into the central nervous system by sequential metabolism. (1992) (113)
- Neural network studies. 1. Estimation of the aqueous solubility of organic compounds (1991) (106)
- Targeting drugs to the brain by redox chemical delivery systems (2000) (104)
- An extended version of a novel method for the estimation of partition coefficients. (1992) (99)
- Soft drugs: Principles and methods for the design of safe drugs (1984) (91)
- Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems (2005) (91)
- Soft drugs—10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: Loteprednol etabonate (1991) (82)
- Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes. (1991) (81)
- Redox Drug Delivery Systems for Targeting Drugs to the Brain a (1987) (76)
- Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease. (2002) (76)
- A new method for the estimation of the aqueous solubility of organic compounds. (1992) (75)
- Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenylethylamine. (1983) (72)
- The potential use of cyclodextrins in parenteral formulations. (1989) (71)
- A simple, predictive, structure‐based skin permeability model (2001) (70)
- Hydroxymethyl and acyloxymethyl prodrugs of theophylline: enhanced delivery of polar drugs through skin (1982) (69)
- Improved delivery through biological membranes. 4. Prodrugs of L-dopa. (1977) (67)
- Redox delivery system for brain-specific, sustained release of dopamine. (1983) (66)
- Micellar acceleration of organophosphate hydrolysis by hydroximinomethylpyridinium type surfactants (1978) (66)
- Novel approaches to the design of safer drugs: soft drugs and site-specific chemical delivery systems (1984) (65)
- Delivery of a quaternary pyridinium salt across the blood-brain barrier by its dihydropyridine derivative (1975) (64)
- Quantitative structure-metabolism relationships: steric and nonsteric effects in the enzymatic hydrolysis of noncongener carboxylic esters. (1999) (61)
- Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins. (1988) (60)
- Soft drugs. 3. A new class of anticholinergic agents. (1980) (56)
- Development of aqueous parenteral formulations for carbamazepine through the use of modified cyclodextrins. (1991) (56)
- Strategies to target kyotorphin analogues to the brain. (1998) (56)
- The effects of cyclodextrins on transdermal delivery of drugs (1991) (55)
- Brain-Targeted Drug Delivery (2003) (55)
- Computer-aided drug design: the role of quantitative structure-property, structure-activity and structure-metabolism relationships (QSPR, QSAR, QSMR) (2002) (55)
- Soft drugs. 2. Soft alkylating compounds as potential antitumor agents. (1980) (53)
- Improved delivery through biological membranes. 1. Synthesis and properties of 1-methyl-1,6-dihydropyridine-2-carbaldoxime, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride. (1976) (53)
- Improved delivery through biological membranes. 13. Brain-specific delivery of dopamine with a dihydropyridine in equilibrium with pyridinium salt type redox delivery system. (1983) (52)
- Enhanced delivery of ganciclovir to the brain through the use of redox targeting (1994) (51)
- Designing safer drugs based on the soft drug approach (1982) (51)
- Reactivity of biologically important reduced pyridines. IV. Effect of substitution on ferricyanide-mediated oxidation rates of various 1,4-dihydropyridines (1989) (49)
- Improved delivery through biological membranes. 3. Delivery of N-methylpyridinium-2-carbaldoxime chloride through the blood-brain barrier in its dihydropyridine pro-drug form. (1976) (49)
- Metabolism, Distribution, and Transdermal Permeation of a Soft Corticosteroid, Loteprednol Etabonate (1992) (49)
- Drug targeting via retrometabolic approaches. (1997) (48)
- Effect of various cyclodextrins on solution stability and dissolution rate of doxorubicin hydrochloride (1992) (48)
- Chapter 30 Prodrugs and Site-Specific Chemical Delivery Systems (1987) (47)
- Improved delivery through biological membranes. XXII. Synthesis and distribution of brain-selective estrogen delivery systems (1987) (47)
- Corticosteroid design for the treatment of asthma: structural insights and the therapeutic potential of soft corticosteroids. (2006) (47)
- Sustained brain-specific delivery of estradiol causes long-term suppression of luteinizing hormone secretion. (1986) (46)
- Octanol–water partition of nonzwitterionic peptides: Predictive power of a molecular size‐based model (1998) (45)
- Theoretical studies of inclusion complexes of β‐cyclodextrin with methylated benzoic acids (1997) (45)
- Prodrugs of 6-thiopurines: enhanced delivery through the skin. (1983) (45)
- The effects of 2-hydroxypropyl-β-cyclodextrin on the solubility and stability of chlorambucil and melphalan in aqueous solution (1989) (45)
- Oral pharmacokinetics of carbamazepine in dogs from commercial tablets and a cyclodextrin complex. (1993) (44)
- All in the mind (1998) (43)
- Soft drugs. 7. Soft beta-blockers for systemic and ophthalmic use. (1988) (43)
- Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. (1997) (43)
- Theoretical studies of inclusion complexes of α- and β-cyclodextrin with benzoic acid and phenol (1997) (43)
- Brain, blood, and cerebrospinal fluid distribution of a zidovudine chemical delivery system in rabbits. (1991) (42)
- A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits. (1992) (41)
- N-Halo derivatives V: Comparative antimicrobial activity of soft N-chloramine systems. (1976) (41)
- A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits. (1992) (41)
- A non-surfactant formulation for alfaxalone based on an amorphous cyclodextrin : activity studies in rats and dogs (1990) (40)
- Improved delivery through biological membranes. 26. Design, synthesis, and pharmacological activity of a novel chemical delivery system for beta-adrenergic blocking agents. (1988) (40)
- Evaluation of a brain-targeting zidovudine chemical delivery system in dogs (1997) (39)
- Improved delivery through biological membranes XD: Percutaneous absorption and metabolism of methylsulfinylmethyl 2-acetoxybenzoate and related aspirin prodrugs. (1981) (38)
- Brain-specific chemical delivery systems for beta-lactam antibiotics. Synthesis and properties of some dihydropyridine and dihydroiosquinoline derivatives of benzylpenicillin. (1989) (38)
- Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins. (1989) (38)
- Formation, stability, and protonation of dihydropyridines. A MINDO/3 study (1978) (37)
- Receptor binding studies of soft anticholinergic agents (2001) (37)
- Improved delivery through biological membranes XIV: Brain-specific, sustained delivery of testosterone using a redox chemical delivery system. (1984) (37)
- Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs. (1992) (37)
- A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats. (1987) (36)
- The use of 2-hydroxypropyl-β-cyclodextrin as a vehicle for intravenous administration of dexamethasone in dogs (1990) (36)
- Rational development of a soluble prodrug of a cytotoxic nucleoside: preparation and properties of arabinosyladenine 5'-formate. (1975) (36)
- Direct evidence for brain-specific release of dopamine from a redox delivery system. (1985) (36)
- Improved delivery through biological membranes. 32. Synthesis and biological activity of brain-targeted delivery systems for various estradiol derivatives. (1988) (33)
- Improved delivery through biological membranes VIII: Design, synthesis, and in vivo testing of true prodrugs of aspirin. (1981) (33)
- N-Halo derivatives VI: Microbiological and chemical evaluations of 3-chloro-2-oxazolidinones. (1976) (33)
- Theoretical studies on the structures of natural and alkylated cyclodextrins. (1995) (32)
- Targeted drug delivery to the brain via phosphonate derivatives. I. Design, synthesis and evaluation of an anionic chemical delivery system for testosterone (1998) (31)
- Evidence for the reestablishment of copulatory behavior in castrated male rats with a brain-enhanced estradiol-chemical delivery system (1987) (30)
- N-halo derivatives III: stabilization of nitrogen-chlorine bond in N-chloroamino acid derivatives. (1976) (30)
- Improved delivery through biological membranes VII. Dermal delivery of cromoglycic acid (cromolyn) via its prodrugs (1980) (30)
- Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites (2004) (30)
- Metabolism-based brain-targeting system for a thyrotropin-releasing hormone analogue. (1999) (29)
- Improved delivery through biological membranes. 2. Distribution, excretion, and metabolism of N-methyl-1,6-dihydropyridine-2-carbaldoxime hydrochloride, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride. (1976) (29)
- The photoelectron spectra of some heterocyclic compounds which contain N, O, Cl and Br (1978) (29)
- A dihydropyridine conjugate which generates high and sustained levels of the corresponding pyridinium salt in the brain does not exhibit neurotoxicity in cynomolgus monkeys (1988) (29)
- Elimination of a quaternary pyridinium salt delivered as its dihydropyridine derivative from brain of mice. (1978) (29)
- Potential Treatment of Herpes Simplex Virus Encephalitis by Brain‐Specific Delivery of Trifluorothymidine Using a Dihydropyridine ⇆ Pyridinium Salt Type Redox Delivery System (1986) (28)
- IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. 13. BRAIN-SPECIFIC DELIVERY OF DOPAMINE WITH A DIHYDROPYRIDINE ⇌ PYRIDINIUM SALT TYPE REDOX DELIVERY SYSTEM (1983) (28)
- Chronic weight loss in lean and obese rats with a brain-enhanced chemical delivery system for estradiol (1988) (27)
- Soft drugs. 12. Design, synthesis, and evaluation of soft bufuralol analogues. (2000) (27)
- A convenient synthesis of (acyloxy)alkyl .alpha.-ethers of phenols (1983) (27)
- Chemical delivery systems for some penicillinase-resistant semisynthetic penicillins. (1989) (27)
- [29] Targeting of drugs to the brain (1985) (26)
- Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro. (1989) (25)
- Soft glucocorticoid design: structural elements and physicochemical parameters determining receptor-binding affinity. (2004) (25)
- Solubilization and Stabilization of a Benzylpenicillin Chemical Delivery System by 2-Hydroxypropyl-β-cyclodextrin (1991) (25)
- Short acting soft mydriatics. (1991) (25)
- Improved delivery through biological membranes. XLI. Brain-enhanced delivery of chlorambucil (1989) (25)
- Antimicrobial activity of N-chloramine compounds. (1980) (24)
- Preparation, Characterization, and Anesthetic Properties of 2-Hydroxypropyl-β-cyclodextrin Complexes of Pregnanolone and Pregnenolone in Rat and Mouse (1995) (24)
- An AM1 molecular orbital study of α-D-glucopyranose and β-maltose : evaluation and implications (1993) (24)
- Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantation. (2010) (24)
- Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats. (1989) (24)
- Soft corticosteroids for local immunosuppression: exploring the possibility for the use of loteprednol etabonate for islet transplantation. (2008) (24)
- Improved delivery through biological membranes XIX: Novel redox carriers for brain-specific chemical delivery systems. (1985) (23)
- Designing safer ophthalmic drugs by soft drug approaches. (1994) (23)
- IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. 4. PRODRUGS OF L-DOPA (1978) (23)
- Effect of molecular manipulation on the estrogenic activity of a brain-targeting estradiol chemical delivery system. (1994) (23)
- Improved delivery through biological membranes. XXX. Synthesis and biological aspects of a 1,4-dihydropyridine based chemical delivery system for brain-sustained delivery of hydroxy CCNU. (1987) (23)
- Ocular delivery of the beta-adrenergic antagonist alprenolol by sequential bioactivation of its methoxime analogue. (1995) (23)
- Targeted drug delivery to the brain via phosphonate derivatives II. Anionic chemical delivery system for zidovudine (AZT) (1998) (23)
- Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach. (1983) (23)
- Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol. (1989) (22)
- Soft drugs 4. 3-Spirothiazolidines of hydrocortisone and its derivatives (1982) (22)
- Molecular Size-Based Model To Describe Simple Organic Liquids (1998) (22)
- A NOVEL CHLORAMINE COMPOUND FOR WATER DISINFECTION1 (1981) (22)
- Novel ‘soft’ β-blockers as potential safe antiglaucoma agents (1988) (21)
- Improved anticonvulsant activity of phenytoin by a redox brain delivery system I: Synthesis and some properties of the dihydropyridine derivatives. (1989) (21)
- Soft drugs V: Thiazolidine-type derivatives of progesterone and testosterone. (1982) (21)
- Brain-Targeted Delivery of Estrogens (1990) (21)
- N-Halo derivatives IV: Synthesis of low chlorine potential soft N-chloramine systems. (1976) (21)
- Recent advances in the design and development of soft drugs. (2014) (21)
- Properties of a new chloramine disinfectant and detoxicant. (1982) (20)
- Reactivity of biologically important reduced pyridines V. Relative importance of electron versus proton loss in ferricyanide-mediated oxidation of dihydronicotinamides (1989) (20)
- Effect of oleic acid on diffusion of drugs through hairless mouse skin. (1989) (20)
- Physicochemical aspects of the enzymatic hydrolysis of carboxylic esters. (2002) (20)
- Improved anticonvulsant activity of phenytoin by a redox brain delivery system. III: Brain uptake and pharmacological effects. (1989) (20)
- THE STABILITY IN WATER OF A NEW CHLORAMINE DISINFECTANT (1983) (20)
- Predicting partition coefficients for isomeric diastereoisomers of some tripeptide analogs (1991) (20)
- Formation of propranolol in the iris-ciliary body from its propranolol ketoxime precursor: a potential antiglaucoma drug (1989) (20)
- Retrometabolic drug design: Principles and recent developments (2008) (19)
- Synthesis and pharmacological effects of new, N‐substituted soft anticholinergics based on glycopyrrolate (2005) (19)
- Potency and Specificity of the Pharmacological Action of a New, Antiasthmatic, Topically Administered Soft Steroid, Etiprednol Dicloacetate (BNP-166) (2003) (19)
- Theoretical Insights into the Formation, Structure, and Energetics of Some Cyclodextrin Complexes (2002) (19)
- Design, synthesis, and pharmacokinetic evaluation of a chemical delivery system for drug targeting to lung tissue. (1996) (19)
- Improved delivery through biological membranes IX: Kinetics and mechanism of hydrolysis of methylsulfinymethyl 2-acetoxybenzoate and related aspirin prodrugs. (1981) (19)
- Evidence for prolonged suppression of stress-induced release of adrenocorticotropic hormone and corticosterone with a brain-enhanced dexamethasone-redox delivery system. (1989) (18)
- Permeability of a soft steroid, loteprednol etabonate, through an excised rabbit cornea. (1996) (18)
- Asymmetric synthesis of enantiomeric cyclophosphamides (1983) (18)
- Soft Drugs 19. Pharmacokinetics, Metabolism and Excretion of a Novel Soft Corticosteroid, Loteprednol Etabonate, in Rats (1995) (18)
- A redox system for brain targeted estrogen delivery causes chronic body weight decrease in rats. (1988) (18)
- Contributions of Molecular Orbital Techniques to the Study of Dihydropyridines (1994) (18)
- Oxidation of aryloxyaminoalcohols with activated dimethylsulfoxide; a novel C-N oxidation facilitated by neighboring group effect (1989) (18)
- Soft drugs. 21. Design and evaluation of soft analogs of propantheline. (1996) (17)
- In Vitro and In Vivo Evaluations of Dihydroquinoline- and Dihydroisoquinoline-based Targetor Moieties for Brain-specific Chemical Delivery Systems (2002) (17)
- Ocular-specific delivery of timolol by sequential bioactivation of its oxime and methoxime analogs. (1997) (17)
- Anxiolytic activity of a brain delivery system for GABA (2004) (17)
- Soft cannabinoid analogues as potential anti-glaucoma agents. (2002) (16)
- A rapid, sensitive method for the simultaneous quantitation of estradiol and estradiol conjugates in a variety of tissues: assay development and evaluation of the distribution of a brain-enhanced estradiol-chemical delivery system. (1989) (16)
- Computer-assisted design of new drugs based on retrometabolic concepts. (1998) (16)
- Retrometabolism‐Based Drug Design and Targeting (2010) (16)
- Recent advances in retrometabolic design approaches. (1999) (16)
- Antihypertensive activity of redox derivatives of tryptophan. (1990) (16)
- Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol. (1988) (16)
- Novel soft steroids: effects on cell growth in vitro and on wound healing in the mouse (1991) (15)
- Novel 'soft' anticholinergic agents. (1988) (15)
- Synthesis and evaluation of a redox chemical delivery system for brain-enhanced dopamine containing an activated carbamate-type ester. (1994) (15)
- Soft Drugs 18. Oral and Rectal Delivery of Loteprednol Etabonate, a Novel Soft Corticosteroid, in Rats—for Safer Treatment of Gastrointestinal Inflammation (1995) (15)
- Controlled delivery of theophylline: chemistry of 7-acyl- and 7,7'-acylditheophylline derivates. (1978) (15)
- Effects of a brain-enhanced chemical delivery system for estradiol on body weight and serum hormones in middle-aged male rats. (1988) (15)
- Reactivity of biologically important reduced pyridines (1990) (15)
- Retrometabolic drug design concepts in ophthalmic target-specific drug delivery (1995) (15)
- Brain-Targeting Chemical Delivery Systems and Their Cyclodextrin-Based Formulations in Light of the Contributions of Marcus E. Brewster. (2016) (15)
- Soft drugs. 12: Design, syntheses and evaluation of soft anticholinergics. (1993) (15)
- High-Performance Liquid Chromatographic Assay of a Central Nervous System (CNS)-Directed Estradiol Chemical Delivery System and Its Application After Intravenous Administration to Rats (1988) (14)
- Improved Delivery Through Biological Membranes. LVI. Pharmacological Evaluation of Alprenoxime—A New Potential Antiglaucoma Agent (1991) (14)
- Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant. (2010) (14)
- New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, Estredox (2004) (14)
- Soft quaternary anticholinergics: comprehensive quantitative structure-activity relationship (QSAR) with a linearized biexponential (LinBiExp) model. (2006) (14)
- Novel, cell‐penetrating molecular transporters with flexible backbones and permanently charged side‐chains (2007) (14)
- Design of Biologically Safer Chemicals (1996) (14)
- Retrometabolic Drug Design and Targeting: Bodor/Retrometabolic Drug Design and Targeting (2012) (14)
- Neural network studies. 4. An extended study of the aqueous solubility of organic compounds (1992) (13)
- Chemical systems for delivery of antiepileptic drugs to the central nervous system (1992) (13)
- Dichloroacetate derivatives. Metabolic effects and pharmacodynamics in normal rats. (1987) (13)
- Design, Pharmacokinetic, and Pharmacodynamic Evaluation of a New Class of Soft Anticholinergics (2003) (13)
- Redox derivatives of tranylcypromine: syntheses, properties, and monoamine oxidase inhibitor activity of some chemical delivery systems. (1991) (13)
- Reactivity of biologically important reduced pyridines. VIII. A semiempirical (AM1) study of the oxidation of 3‐substituted‐1‐methyl‐1,4‐dihydropyridines (1991) (13)
- Effects of a brain-enhanced estrogen delivery system on tail-skin temperature of the rat: implications for menopausal hot flush. (1991) (13)
- Effect of cyclodextrins on the solubility and stability of a novel soft corticosteroid, loteprednol etabonate. (2000) (13)
- Soft Drugs Based on Hydrocortisone: The Inactive Metabolite Approach and Its Application to Steroidal Antiinflammatory Agents (1999) (12)
- Pharmacokinetic and Pharmacodynamic Evaluations of the Zwitterionic Metabolite of a New Series of N-Substituted Soft Anticholinergics (2005) (12)
- Improved Delivery through Biological Membranes. Synthesis, Characterization and Antiviral Activity of a Series of Ribavirin Chemical Delivery Systems: 5 and Carboxamide Derivatives (1991) (12)
- Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma. (1997) (12)
- Brain-enhanced delivery of testosterone using a chemical delivery system complexed with 2-hydroxypropyl-beta-cyclodextrin. (1988) (12)
- Reactivity of biologically important reduced pyridines. 2. Oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). MNDO study (1988) (12)
- The Effect of Vehicle Additives on the Transdermal Delivery of Nitroglycerin (1987) (12)
- Retrometabolic approaches for drug design and targeting. (1997) (12)
- Soft Drugs. XX. Design, Synthesis, and Evaluation of Ultra-Short Acting Beta-Blockers (1995) (11)
- Improved delivery through biological membranes XX: Nicotinamide----dihydronicotinamide based ester-linked redox carrier systems. (1986) (11)
- Application of semiempirical molecular orbital techniques to the study of peroxidase-mediated oxidation of phenols, anilines, sulfides and thiobenzamides (1991) (11)
- A rapid, quantitative in vivo assay for narcotic antagonists. (1984) (11)
- Formulation development for a zidovudine chemical delivery system 2. Towards oral and non-parenteral dosage forms (1995) (11)
- Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2 (1984) (11)
- Improved Delivery Through Biological Membranes. XXXVII. Synthesis and Stability of Novel Redox Derivatives of Naproxen and Indomethacin (1989) (11)
- The Effect of Dihydronicotinate N-Substitution on the Brain-Targeting Efficacy of a Zidovudine Chemical Delivery System (1993) (11)
- Dose-Dependent Brain Delivery of Zidovudine Through the Use of a Zidovudine Chemical Delivery System (1995) (11)
- Redox targeting of LY231617, an antioxidant with potential use in the treatment of brain damage (1996) (11)
- Cardiovascular studies on different classes of soft drugs. (2000) (11)
- Brain and CSF specific chemical delivery systems for beta-lactam antibiotics. Study of two dihydropyridine derivatives of benzylpenicillin in rabbits and dogs. (1990) (11)
- Novel approaches to design and deliver safe and effective antiglaucoma agents to the eye (1994) (11)
- Brain-targeted chemical delivery of [Leu2, Pip3]-TRH: synthesis and biological evaluation. (2000) (10)
- On the reactivity of CFnH3−nCH2X (n = 0, 1, 2, and 3, and X = H or Halogen atom) (1992) (10)
- Improved Delivery through Biological Membranes. Synthesis and Antiviral Activity of a Series of Ribavirin Chemical Delivery Systems: 2′ and 3′ Derivatives (1991) (10)
- Improved delivery of acyclovir to the skin using a dihydrotrigonelline trigonelline redox carrier (1991) (10)
- Effects of a Brain-Enhanced Chemical Delivery System for Estradiol on Body Weight and Food Intake in Intact and Ovariectomized Rats (1989) (10)
- Determination of penicillins and cephalosporins using 3-bromo-4,4-dimethyl-2-oxazolidinone (1979) (10)
- Redox approaches to drug delivery to the central nervous system. (1992) (10)
- Formulation development for a zidovudine chemical delivery system 1. Parenteral dosage forms (1995) (10)
- Soft drugs--XVI. Design, evaluation and transdermal penetration of novel soft anticholinergics based on methatropine. (1993) (10)
- Design and evaluation of new soft anticholinergic agents (1998) (10)
- Improved anticonvulsant activity of phenytoin by a redox brain delivery system. II: Stability in buffers and biological materials. (1989) (10)
- Pharmacokinetics of the sequential metabolites of loteprednol etabonate in rats (2008) (10)
- Efficacy of a 3-substituted versus 17-substituted chemical delivery system for estradiol brain targeting. (1995) (10)
- Theoretical studies on the hydride transfer between 1-methyl-1,4-dihydronicotinamide and its corresponding pyridinium salt (1988) (10)
- Identification of esterase involved in the metabolism of two corticosteroid soft drugs (2017) (10)
- Techniques of Solubilization of Drugs. (Drugs and the Pharmaceutical Sciences Series, Vol 12.) (1984) (10)
- Cardiac electrophysiologic effects of adaprolol maleate, a new beta-blocker, in closed chest dogs. (1991) (9)
- Retrometabolic drug design--novel aspects, future directions. (2001) (9)
- The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues. I. Dose-response and time-course evaluation. (1991) (9)
- Improved delivery through biological membranes VI. Potent sympathomimetic adrenalone derivatives (1978) (9)
- Improved Delivery Through Biological Membranes LX: Intradermal Targeting of Acyclovir Using Redox-Based Chemical Drug Delivery Systems (1996) (9)
- Brain-targeted delivery of estradiol (2006) (9)
- Design, synthesis, and pharmacological evaluation of soft glycopyrrolate and its analog. (2000) (9)
- A Dihydroisoquinoline Targetor-Based Acid Resistant Chemical Delivery System of Azidothymidine (AZT) (1993) (9)
- AM1-BASED MODEL SYSTEM FOR ESTIMATION OF BRAIN/BLOOD CONCENTRATION RATIOS (1996) (9)
- Structure-based estimation of enzymatic hydrolysis rates and its application in computer-aided retrometabolic drug design. (2000) (9)
- Improved Delivery Through Biological Membranes. XLV. Synthesis, Physical-Chemical Evaluation, and Brain Uptake Studies of 2-Chloroethyl Nitrosourea Delivery Systems (1992) (9)
- Retrometabolic approaches to drug targeting. (1995) (9)
- Applications of chemically-modified cyclodextrins: use of hydroxypropyl-β-cyclodextrin as an enabling excipient for brain targeting, redox-based derivatives of estradiol A review of preclinical and clinical findings (2004) (9)
- Improved delivery through biological membranes. XII. The effect of the incorporation of biphasic solubilizing groups into prodrugs of steroids (1983) (9)
- In vitro evaluation of a controlled-release site-specific diisovaleryl tert-butalone chemical delivery system for the eye. (1994) (9)
- Correlation between hydride transfer and one-electron oxidation of dihydropyridines and heterocycles (1988) (9)
- Soft drugs--XIV. Synthesis and anticholinergic activity of soft phenylsuccinic analogs of methatropine. (1993) (9)
- Reactivity of biologically important reduced pyridines VI. Lack of through-resonance stabilization in the ferricyanide-mediated oxidation of substituted 1-Phenyl-1,4-Dihydronicotinamides (1990) (9)
- Minimal cardiac electro-physiological activity of alprenoxime, a site-activated ocular β-blocker, in dogs (1995) (9)
- QSAR Study of 2,3‐Benzodiazepin‐4(thi)one‐ and 1,2‐Phthalazine‐Related Negative Allosteric Modulators of the AMPA Receptor: A Structural Descriptors‐Based Reassessment (2005) (8)
- Application of a Brain-Targeting Chemical Delivery System to 9-Amino-1,2,3,4-Tetrahydroacridine (1990) (8)
- Sequential bioactivation of methoxime analogs of beta-adrenergic antagonists in the eye. (1995) (8)
- Ionic and radical intermediates of 3-substituted 5,6-dihydro-1,4,2-dioxazines: a theoretical (AM1) study (1991) (8)
- Dithionite reduction of pyridinium salts: an AM1 study (1993) (8)
- Recent advances in retrometabolic drug design and targeting approaches. (2000) (8)
- Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs. (2002) (8)
- Soft drugs. 13: Design and evaluation of phenylsuccinic analogs of scopolamine as soft anticholinergics. (1993) (8)
- Enhanced brain delivery of 2′-fluoro-5-methylarabinosyluracil (1992) (8)
- Intraocular Pressure-Lowering Activity and In Vivo Disposition of Dipivalyl Terbutalone in Rabbits (2001) (8)
- Neural network studies 2. Use of a neural net to estimate oxidation energies for substituted dihydropyridines and related heterocycles (1992) (8)
- Electronic structures of some antimicrobial N-chloramines. Possible existence of intramolecular hydrogen bonding and its effect on germicidal efficiency. (1978) (8)
- Substituent effects on the stability of 1,4-dihydropyridines (1995) (8)
- Regioselective O-alkylation of cortienic acid and synthesis of a new class of glucocorticoids containing a 17α-alkoxy, a 17α-(1′-alkoxyethyloxy), a 17α-alkoxymethyloxy, or a 17α-methylthiomethyloxy function (1991) (8)
- The pharmacokinetics and transdermal delivery of loteprednol etabonate and related soft steroids (1994) (8)
- Theoretical am1 studies of inclusion complexes of α- and β-cyclodextrins with methylated benzoic acids and phenol, and γ-cyclodextrin with buckminsterfullerene (1996) (8)
- A convenient method of anion exchange in quaternary salts (1978) (8)
- Improved brain delivery of antiviral agents through the use of redox targeting (1994) (8)
- Soft drugs. 17: Quantitative structure-activity relationships of soft anticholinergics based on methatropine and methscopolamine. (1994) (8)
- Recent advances in retrometabolic drug design (RMDD) and development. (2010) (7)
- Selective 17α-Alkylation of Cortienic Acid Derivatives in a Solid-Liquid Biphasic System (1990) (7)
- Rotational barriers in phenol and sterically congested phenol derivatives, an AM1 study (1994) (7)
- Quantitative Evaluation of the Reactivity of Alkylating Agents (1980) (7)
- New Water-Soluble Pilocarpine Derivatives with Enhanced and Sustained Muscarinic Activity (1992) (7)
- Synthesis, characterization and in vitro evaluation of various sulfonamide chemical delivery systems (1991) (7)
- Reactivity of biologically important reduced pyridines. 7. Energetics and effect of substitution on hydride versus electron transfer in dihydropyridines, dihydroquinolines, and dihydroisoquinolines (1990) (7)
- Extension of a redox-based chemical delivery system to alpha, beta-unsaturated ketones. (1990) (7)
- Improved delivery through biological membranes. XXI. Brain-targeted anti-convulsive agents. (1990) (7)
- Tissue distribution of a brain-enhanced chemical delivery system for estradiol. (1990) (7)
- Facile, One-Step Preparation of Trigonellinate Esters (1987) (7)
- On the structure of N‐chlorosuccinimide and N‐bromosuccinimide. A photoelectron spectroscopic study (1978) (7)
- Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate--syntheses and pharmacological evaluations. (2008) (7)
- Fast atom bombardment and tandem mass spectrometry of quaternary pyridinium salt-type tryptophan derivatives (1993) (7)
- Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse. (1995) (6)
- Improved delivery through biological membranes. Synthesis, distribution, and neurochemical effects of a tryptamine chemical delivery system. (1986) (6)
- Syntheses and Preliminary Pharmacological Evaluation of Some Chemical Delivery Systems of 2,6‐Diisopropylphenol (Propofol). (1992) (6)
- Growth Hormone (GH) Secretory Dynamics in Animals Administered Estradiol Utilizing a Chemical Delivery System (1990) (6)
- Extended covalent solid forms of carbon dioxide with carbon–oxygen single bonds (2000) (6)
- Minimal cardiac electrophysiological activity of alprenoxime, a site-activated ocular beta-blocker, in dogs. (1995) (6)
- DRUG TARGETING BY RETROMETABOLIC DESIGN: SOFT DRUGS AND CHEMICAL DELIVERY SYSTEMS (2001) (6)
- Targeting drugs to the brain by sequential metabolism. (1995) (6)
- A Redox-Based System that Enhances Delivery of Estradiol to the Brain: Pharmacokinetic Evaluation in the Dog (1990) (6)
- Unified Pharmacogenetics-Based Parent–Metabolite Pharmacokinetic Model Incorporating Acetylation Polymorphism for Talampanel in Humans (2005) (6)
- The electronic structures of some biological piperazines (1978) (6)
- Improved delivery through biological membranes XXV. Enhanced and sustained delivery of trifluorothymidine to the brain using a dihydropyridine in equilibrium pyridinium salt type redox delivery system. (1987) (6)
- Targeted drug delivery to the central nervous system via phosphonate derivatives (anionic delivery system for testosterone). (2002) (6)
- Targeting of Neuropharmaceuticals by Chemical Delivery Systems (2007) (6)
- Resolution of chiral phosphamides (1980) (6)
- Chemical delivery systems: evaluation of physicochemical properties and enzymatic stability of phenylephrone derivatives. (1999) (6)
- Use of a Chemical Redox System for Delivery of Drugs to the Brain: Ethinyl Estradiol (1988) (6)
- Theoretical study of some heterocyclic amines with applications to the chemistry of 9‐amino‐1,2,3,4‐tetrahydroacridine (1989) (5)
- Comparative evaluation of Estredox, a brain-targeted estradiol delivery system versus traditional estrogen replacement therapy. (2006) (5)
- ANALOGS OF TRYPTOPHAN (1994) (5)
- Octanol-Water Partition: Searching for Predictive Models (1998) (5)
- Brain-Enhanced Delivery of Anti-Dementia Drugs (1989) (5)
- Dose and Time-Course Evaluation of a Redox-Based Estradiol-Chemical Delivery System for the Brain. I. Tissue Distribution (1990) (5)
- Mass spectra of a series of 3‐halo‐2‐oxazolidinones (1977) (5)
- Novel Redox Derivatives of Tryptophan (1994) (5)
- IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES: PREPARATION AND INVESTIGATION OF STABLE DOPAMINE CHEMICAL DELIVERY SYSTEM SAMPLES (1993) (5)
- Studies on a soft glycopyrrolate analog, SG-1. (2002) (5)
- Optimized structures and relative stabilities of the isomers of (CO2)2n+1 (1 ⩽ n ⩽6) from AM1 calculations (1992) (5)
- Novel Chemical Approaches for Sustained Drug Delivery (1987) (5)
- Isomerism of cephalosporin esters; theoretical and practical aspects (1994) (5)
- The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues. II. The role of testosterone. (1991) (5)
- A theoretical study of the hydrolysis of some sterically hindered phenolic esters (1992) (5)
- Solubilization and electrochemical stabilization of substituted phenols through the use of 2-hydroxypropyl-β-cyclodextrin (1994) (5)
- Design, in vitro stability, and ocular hypotensive activity of t-butalone chemical delivery systems. (2001) (4)
- 28-day oral toxicity study with soft corticosteroid BNP-166 in rats and dogs, followed by a 14-day recovery period. (2002) (4)
- Computational Approaches to the Design of Safer Drugs and Their Molecular Properties (1996) (4)
- Improved Delivery Through Biological Membranes. XVII. A Site-Specific Chemical Delivery System as a Short-Acting Mydriatic Agent (1984) (4)
- 13C NMR spectroscopy of 4,5- and 5,6-double bond isomers of spiro-3-steroidal ketone derivatives (1981) (4)
- Erratum: Octanol‐Water partition of nonzwitterionic peptides: Predictive power of a molecular size‐based model. Proteins 30:86–99, 1998 (1998) (4)
- PREPARATION OF REDOX DERIVATIVES OF 3α-HYDROXY-5α-PREGNANE-11,20-DIONE (1994) (4)
- Anti-inflammatory effect and soft properties of etiprednol dicloacetate (BNP-166), a new, anti-asthmatic steroid. (2004) (4)
- Novel central nervous system targeted semisynthetic penicillins. (1990) (4)
- Metabolic properties of phosphonate esters. (2004) (4)
- Influence of the N-acetylation polymorphism on the metabolism of talampanel: an investigation in fasted and fed subjects genotyped for NAT2 variants. (2006) (4)
- Stabilization of aspartame by cyclodextrins (1991) (4)
- Application of a brain specific chemical delivery system approach to tranylcypromine (1990) (4)
- Loteprednol etabonate, a new soft steroid is effective in a rabbit acute experimental model for arthritis. (1999) (4)
- SCFMO Study of the Tautomerism of Anilino-Thiazole and Related Compounds (1971) (4)
- Intravenous and Buccal 2-Hydroxypropyl-β-Cyclodextrin Formulations of E2-CDS — Phase I Clinical Trials (1996) (4)
- Nitrogen radical cations as intermediates in enzymatically mediated oxidative deaminations—application of molecular parametric models (1995) (4)
- A tryptamine analog with high affinity to the heart tissues is a potential antiarrhythmic agent (2001) (4)
- Improved delivery through biological membranes. LXI: Design, synthesis, and evaluation of a lipolol-based intradermal drug targeting system for 5-fluorouracil. (1994) (4)
- Targeting of drugs to the brain. (1985) (3)
- Borohydride reduction of imidazolidino[1,2-d]dithiadiazepines (1992) (3)
- Improved delivery through biological membranes XVI. Enhancement of the brain-specificity of a dihydropyridine formed from pyridinium salt drug delivery system by controlled infusion. (1983) (3)
- Improved parenteral formulations for traditional antiepileptics. (1994) (3)
- Design, pharmacokinetic, and pharmacodynamic evaluation of soft anticholinergics based on tropyl alpha-phenylcyclopentylacetate. (2002) (3)
- Preparation and biological effects of pure stereoisomeric novel soft anticholinergics. (2006) (3)
- Soft drugs 15: mydriatic activity and transcorneal penetration of phenylsuccinic soft analogs of methscopolamine as short acting mydriatics. (1993) (3)
- Targeted Drug Delivery (1991) (3)
- Chemical delivery systems for drugs containing an amino group: synthesis and properties of some pyridine derivatives of desipramine. (1989) (3)
- A study of the penetration of five novel synthetic steroids through hairless mouse skin in vitro (1985) (3)
- Structural studies of bitetrahedryl molecule C8H6, coupled tricyclo[3.1.0.0]hexyl molecule C12H14, and coupled bicyclo[1.1.0]butane derivatives (1992) (3)
- Design of Biologically Safer Chemicals Based on Retrometabolic Concepts (1996) (3)
- Acid-catalyzed rearrangements of the dihydroxyacetone side chain in steroids during ketal exchange (1978) (3)
- Soft Anticholinergics (1996) (3)
- Tissue distribution of LY231617, an antioxidant with neuroprotectant activity, in the rat. (1995) (3)
- A Redox-Based Chemical Delivery System that Enhances Estradiol Distribution to the Brain: Disposition Studies in the Rat (1991) (3)
- A CONVENIENT SYNTHESIS OF (ACYLOXY)ALKYL α-ETHERS OF PHENOLS (1984) (3)
- Theoretical study of the stereoisomers of tetrahydrocannabinols (1997) (3)
- Hydrolytic stability of allylic and phenolic esters of some synthetic cannabinoids: A theoretical (AM1) study (1995) (2)
- SOFT STEROIDS HAVING ANTI-NFLAMMATORY ACTIVITY (2017) (2)
- Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites. (2002) (2)
- Water soluble pilocarpine prodrugs with sustained intraocular activity in normotensive rabbits and in glaucomatous beagles (1994) (2)
- Delivery of peptides into the central nervous system by sequential metabolism (1994) (2)
- Dose and Time-Course Evaluation of a Redox-Based Estradiol-Chemical Delivery System for the Brain. II. Pharmacodynamic Responses (1990) (2)
- The Drug Discovery and Development Process (2012) (2)
- Improved delivery of acyclovir to the skin using a dihydrotrigonelline in equilibrium with trigonelline redox carrier. (1991) (2)
- The effects of delta1-cortienic acid on skin blanching, pharmacokinetics and stability of loteprednol etabonate. (2012) (2)
- Identification of Major Esterase Involved in Hydrolysis of Soft Anticholinergic (2R3'R-SGM) Designed From Glycopyrrolate in Human and Rat Tissues. (2019) (2)
- Enhanced Activity of Topical Hydrocortisone by Competitive Binding of Corticosteroid-Binding Globulin. (2016) (2)
- IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. 11. A REDOX CHEMICAL DRUG-DELIVERY SYSTEM AND ITS USE FOR BRAIN-SPECIFIC DELIVERY OF PHENYLETHYLAMINE (1983) (2)
- PREPARATION OF O-(3,3,8,10,10-PENTAMETHYL-1,2-DITHIA-5,8-DIAZACYCLODECAN-5-YL)ETHYL O-PIVALOYLOXYMETHYL PHENYLPHOSPHONATE (1998) (2)
- Soft cannabinoid analogues as potential anti-glaucoma agents. (2000) (2)
- SOFT DRUGS. 2. SOFT ALKYLATING COMPOUNDS AS POTENTIAL ANTITUMOR AGENTS (1980) (2)
- Retrometabolic Drug Design (2012) (2)
- Synthesis and pharmacological evaluation of prodrugs of valproic acid. (2000) (2)
- N-HALO DERIVATIVES. III- STABILIZATION OF NITROGEN-CHLORINE BOND IN N-CHLOROAMINO ACID DERIVATIVES (1976) (2)
- Water Soluble Complexes of a Brain-Targeted Drug Delivery System (1988) (2)
- Quantitative Structure Activity Relationships of Catechol Derivatives on Nerve Growth Factor Secretion in L-M Cells (1995) (2)
- Acylation of the 4,5- and 5,6-double bond isomers of 3-steroidal thiazolidines: The chemical stability of spiro-3-steroidal 4,5- and 5,6-double bond isomers (1981) (2)
- IN-VIVO ELIMINATION OF DIHYDROPYRIDINE DRUG DELIVERY CARRIERS FROM BRAIN AND BLOOD OF RATS (1986) (2)
- Synthesis and evaluation of novel lidocaine sulfur analogs (1984) (2)
- Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats. (2010) (2)
- Anesthetic Activity and Pharmacokinetics of the Neurosteroid Alfaxalone Formulated In 2-Hydroxypropyl-β-Cyclodextrin in the Rat (1996) (2)
- HPLC separation of related impurities in etiprednol dicloacetate, a novel soft corticosteroid. (2004) (2)
- Glucocorticoid activity and structure activity relationships in a series of some novel 17 alpha-ether-substituted steroids: influence of 17 alpha-substituents. (1991) (2)
- Intermolecular interactions of methyl acetate, β‐propiolactone, ethyl acetate, and γ‐butyrolactone: An AM1 semiempirical study (1992) (2)
- Mechanism of Drug Action: Basic Concepts (2012) (1)
- PRODRUGS OF 6-THIOPURINES: ENHANCED DELIVERY THROUGH THE SKIN (1983) (1)
- Relative reactivity of 1,4‐ and 1,6‐dihydronicotinic acid derivatives to radically mediated oxidation—a theoretical and experimental evaluation (1995) (1)
- Pharmacological effects of some newly developed soft anticholinergics and a receptor-binding QSAR study. (2006) (1)
- Stability of the 1,3-substituted 1,4-dihydropyridines: Substituent effects on the acid catalyzed hydration and oxidation reactions (1994) (1)
- Brain-targeted delivery of peptides (2006) (1)
- A Brain-Enhanced Chemical Delivery System for Gonadal Steroids: Implications for Neurodegenerative Diseases (1989) (1)
- SOFT DRUGS. V: THIAZOLIDINE-TYPE DERIVATIVES OF PROGESTERONE AND TESTOSTERONE (1982) (1)
- Quantitative structure–inhibitory activity relationships of substituted phenols on bacillus subtilis spore germination (1994) (1)
- Response to the commentary on “pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs” (1994) (1)
- Improved Oral Bioavailability of the Brain-Targeting Estrogen, E2-CDS, through the Use of Carboxymethylethyl-β-Cyclodextrin (1996) (1)
- Design and delivery of ophthalmic drugs : chemical approaches. (1993) (1)
- Selective Reduction of Trigonellyl Group to the Corresponding Dihydropyridine in the Presence of Disulfide Group (2008) (1)
- An AM1 molecular orbital study of alpha-D-glucopyranose and beta-maltose: evaluation and implications. (1993) (1)
- Novel 'soft' beta-blockers as potential safe antiglaucoma agents. (1988) (1)
- Drug Targeting to the Brain and Eye by Chemical/Enzymatic Retrometabolic Approaches (1995) (1)
- A theoretical study of the dithionite reduction of pyridinium salts (1993) (1)
- A theoretical study of prednisolone, 6α-fluoroprednisolone, 9α-fluoroprednisolone, 6α,9α-difluoroprednisolone and related compounds (1993) (1)
- Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties (2023) (1)
- Regioselective O-alkylation of cortienic acid and synthesis of a new class of glucocorticoids containing a 17 alpha-alkoxy, a 17 alpha-(1'-alkoxyethyloxy), a 17 alpha-alkoxymethyloxy, or a 17 alpha-methylthiomethyloxy function. (1991) (1)
- Etiprednol dicloacetate, a new soft glucocorticoid drug candidate. Development of chemistry. (2004) (1)
- Configurational Analysis, Inversion, and Reduction of Some Pyridine Carbaldoximes (1979) (1)
- Isomeric interconversions in tamoxifen and related compounds: An AM1 study (1995) (1)
- Biodistribution of Azidothymidine Mediated by a Highly Lipophilic Chemical Delivery System. (2010) (1)
- Brain targeting of drugs and neuropeptides by retrometabolic design approaches (1997) (1)
- Reactivity of biologically important reduced pyridines: Part 9. Effect of substitution on rotational energetics in 1-phenyl-1,4-dihydropyridine, the 1-phenylpyridinium cation and related systems (1992) (1)
- Determination of estredox, a compound with sustained estradiol function, and its impurity profile by HPLC. (2008) (1)
- SOFT DRUGS. 1. LABILE QUATERNARY AMMONIUM SALTS AS SOFT ANTIMICROBIALS (1980) (0)
- Preparation of O-(3,3,8,10,10-Pentamethyl-1,2-dithia-5,8-diazacyclodecan-5-yl)ethyl O-Pivaloyloxymethyl Phenylphosphonate. (1998) (0)
- Selective 17α-Alkylation of Cortienic Acid Derivatives in a Solid-Liquid Biphasic System. (1990) (0)
- Chemical Aspects of Drug Delivery Systems Edited by D. R. Karsa and R. A. Stephenson. The Royal Society of Chemistry, London. 1996. viii + 162 pp. 15 × 23 cm. ISBN 0-85404-706-9. $89.00. (1996) (0)
- Enhanced Brain Delivery of Amino Acids and Peptides Through the Use of Redox Targeting Systems (1992) (0)
- Isomerism of Cephalosporin Esters. Theoretical and Practical Aspects. (1994) (0)
- Low allergic steroid type anesthetic/hypnotic agent (1990) (0)
- Xanthine derivatives, processes for their manufacture and to compositions comprising drug (1977) (0)
- United States Patent ( 19 ) Bodor (2017) (0)
- The first 40 years of soft anticholinergic agents (2021) (0)
- Cladribine formulations for oral and transmucosal delivery improved (2004) (0)
- Hypoallergenic anesthetic / hypnotic steroidal drug formulation. (1990) (0)
- United States Patent ( 19 ) Bodor 54 REDOX SYSTEMS FOR BRAIN-TARGETED (2017) (0)
- Steroidspirothiazolidinderivate, processes for making them and this drug enhaltende (1979) (0)
- PART 1: DESIGN, SYNTHESIS AND EVALUATION OF NEW SITE-SPECIFIC MONOAMINE OXIDASE INHIBITORS (1998) (0)
- Hydroxyl stretching in substituted phenols: An AM1 study (1993) (0)
- Method for treating male sexual dysfunction us patent 4863911 september 5 1989 (1989) (0)
- Glossary and tutorial of xenobiotic metabolism terms used during small molecule drug discovery and development (IUPAC Technical Report) (2021) (0)
- exercising mild steroid anti-inflammatory activity (1981) (0)
- Phenolic compounds and process for their preparation (1981) (0)
- Transdermal administration system. (1986) (0)
- Synthesis and Evaluation of a Novel Chemical Delivery System of Zidovudine with Increased Stability at Low pH (2011) (0)
- United States Patent ( 19 ) Rand et al . ( 54 ) NMR-ASSAYABLE LIGAND-LABELLED TREFLUOROTHYMIDINE CONTAINING COMPOSITION AND METHOD FOR DAGNOSS OF HSW INFECTION 75 ) Inventors : (2017) (0)
- Analogifremgangsmaade for the preparation of local anti-inflammatory active 17alpha-carbonate-androst-4-en-3-one 17beta-carboxylic acid esters which degrade in vivo to non-toxic metabolites (1981) (0)
- Theoretical aspects of cephalosporin isomerism (2009) (0)
- Apport cible de medicament par l'intermediaire de derives de phosphonate. (1991) (0)
- Steroids, processes for their preparation and pharmaceutical compositions containing the steroids (1981) (0)
- Patent Number : 5 , 082 , 853 45 ) Date of Patent : " Jan . 21 , 1992 54 BRAIN-SPECIFICANALOGUES OF CENTRALLY ACTING AMNES 76 Inventor : (2017) (0)
- Neural Network Studies. Part 2. Reactivity of Biologically Important Reduced Pyridines. Part 10. Use of a Neural Net to Estimate Oxidation Energies for Substituted Dihydropyridines and Related Heterocycles. (1992) (0)
- 6. Chemical Delivery Systems (2012) (0)
- Improved delivery through biological membranes. 39. Brain-specific chemical delivery systems for 26-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats [Erratum to document cited in CA111(8):63813y] (1990) (0)
- oral cladribine formulations. (2004) (0)
- Selective Reduction of Trigonellyl Group to the Corresponding Dihydropyridine in the Presence of Disulfide Group. (2008) (0)
- Oral preparations containing cladribine (2004) (0)
- A Convenient Preparation of Phosphate Diester Monoanions (1990) (0)
- Synthesis and in vitro dopaminergic activity of (2-aminoethyl)-1-hydroxy-2-pyridone type dopamine analogs. (1993) (0)
- Potential treatment of herpes simplex virus encephalitis by brain-specific delivery of trifluorothymidine using a dihydropyridine in equilibrium pyridinium salt type redox delivery system. (1986) (0)
- Passive and facilitative transport of nucleobases, nucleosides, and oligonucleotides--application to antiviral and other therapies. (1995) (0)
- STRUCTURE-ACTIVITY RELATIONSHIPS IN THE ANTIINFLAMMATORY STEROIDS: A PATTERN-RECOGNITION APPROACH (1983) (0)
- Novel Redox Derivatives of Tryptophan. (1994) (0)
- Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations (2023) (0)
- Mercapto compound and the process for its preparation (1981) (0)
- A MINDO/3 study of a substituted benzo[b] isoquinolizinium salt ⇆ benzo[b] quinolizine system (1986) (0)
- Patent Number : 45 Date of Patent : 5 , 389 , 623 Feb (2017) (0)
- Analogues of Tryptophan. (2010) (0)
- Preparation of Redox Derivatives of 3α‐Hydroxy‐5α‐pregnane‐ 11,20‐dione. (1994) (0)
- Drag targeting by site-specific chemical drug delivery systems (1990) (0)
- Improved activity and / or duration of action of soft anti-inflammatory steroids for topical or other local. (2004) (0)
- ACYLATION OF THE 4,5- AND 5,6-DOUBLE BOND ISOMERS OF 3-STEROIDAL THIAZOLIDINES. THE CHEMICAL STABILITY OF SPIRO-3-STEROIDAL 4,5- AND 5,6-DOUBLE BOND ISOMERS (1982) (0)
- 5. Soft Drugs (2012) (0)
- Soft Drugs. Part 12. Design, Synthesis, and Evaluation of Soft Bufuralol Analogues. (2000) (0)
- The use of cortienic acid and its derivatives and analogs as lipophilic carriers for targeted delivery of antiviral agents (1995) (0)
- The effect of phosphine oxides on transdermal delivery. (1990) (0)
- Preparation, Preliminary Characterization and Complexation of a Crystalline Redox‐based Chemical Delivery System for Dopamine (1995) (0)
- SOFT DRUGS. 3. A NEW CLASS OF ANTICHOLINERGIC AGENTS (1980) (0)
- ON THE STRUCTURE OF N-CHLOROSUCCINIMIDE AND N-BROMOSUCCINIMIDE. A PHOTOELECTRON SPECTROSCOPIC STUDY (1978) (0)
- The Response to Vapor Challenges of New Microsensor Coatings: Nicotinic Acid Derivatives. (1990) (0)
- The Effect of 2-Hydroxypropyl-ß-Cyclodextrin on the Solubility, Stability and Brain Targeting of Chemical Delivery Systems for Neuropeptides (1999) (0)
- United States Patent ( 19 ) Bodor ( 54 ) BRAIN-SPECIFICDRUG DELIVERY 75 ) Inventor : (2017) (0)
- A method of preparation of an anesthetic composition or hypoallergenic steroidal hypnotic. (1990) (0)
- Soft analogs of bufuralol: initial pharmacologic evaluation (1999) (0)
- Effect of 2-Hydroxypropyl-β-Cyclodextrin Complexes of the Neurosteroids, Alfaxalone, Pregnanolone and Pregnenolone, on Various Convulsant Stimuli in the Mouse (1996) (0)
- N-HALO DERIVATIVES IV. SYNTHESIS OF LOW CHLORINE POTENTIAL SOFT N-CHLORAMINE SYSTEMS (1977) (0)
- New forms of transient drug precursors of the type xanthine derivatives (1977) (0)
- Prodrug compounds of steroids, process for manufacturing the same, and their use in medicinal products with anti-inflammatory effect (1977) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nicholas Stephen Bodor?
Nicholas Stephen Bodor is affiliated with the following schools:
